Oncologic Samples

The category Oncologic Samples encompasses diverse human biospecimens of benign, in situ and malignant neoplasm samples like Leukaemia, Lymphoma, Breast, Brain, Eye, Lung, Pancreatic, Prostate, Skin or Uterus Cancer. Procurement takes place from consented donors under strict ethical standards. You can use our filter functions to perform complex searches according to laboratory parameters, disease in clear name or ICD-10 code, patient annotation, such as age, gender, BMI and ethnicity. If you do not find the samples you are looking for, please contact us.

Available filters
-
-
26,284 Products

Human Serum - Complement C3 - D47.5

Donor:
Gender: Male Age: 30
Diagnosed disease:
D47.5 - Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Bactericidal / Permeability Increasing Protein (BPI) Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Proteinase 3 (PR3) Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-double-stranded DNA (dsDNA) Beta-CrossLaps (b-CTX) Bone alkaline phosphatase (BAP) Capsule-reactive protein (CRP) ...
Donor:
Gender:
Male
Age:
30 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Chronic eosinophilic leukaemia [hypereosinophilic syndrome] [D47.5]
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: negative
Quant: 44.60 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Bactericidal / Permeability Increasing Protein (BPI)
Qual: negative
Quant: 5.70 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Mutated citrullinated Vimentin (MCV)
Qual: negative
Quant: 9.40 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Myeloperoxidase (MPO)
Qual: negative
Quant: 0.80 U/mL
Source: this donation
< 5.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Proteinase 3 (PR3)
Qual: negative
Quant: 0.70 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: 3.02 RU/mL
Source: this donation
< 5.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-double-stranded DNA (dsDNA)
Qual: negative
Quant: 5.40 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Beta-CrossLaps (b-CTX)
Qual: negative
Quant: 0.259 ng/mL
Source: this donation
0.115 - 0.748 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Bone alkaline phosphatase (BAP)
Qual: negative
Quant: 16.40 µg/L
Source: this donation
5.70 - 32.90 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.11 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: positive
Quant: 0.89 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.16 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Osteocalcin
Qual: negative
Quant: 17.20 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 18.30 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: < 1.00 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 7.30 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH183931
0.5 mL (€56.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - C43.9

Donor:
Gender: Female Age: 48 Ethnic group: European/Caucasian
Diagnosed disease:
C43.9 - Malignant melanoma of skin, unspecified
Medication:
Novaminsulfon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
48 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
72 kg
Height:
159 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant melanoma of skin, unspecified [C43.9]
Medication:
  • Novaminsulfon (Dosages: 500mg, as needed)
  • Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.6 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234438
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - C43.9

Donor:
Gender: Female Age: 48 Ethnic group: European/Caucasian
Diagnosed disease:
C43.9 - Malignant melanoma of skin, unspecified
Medication:
Novaminsulfon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
48 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
72 kg
Height:
159 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant melanoma of skin, unspecified [C43.9]
Medication:
  • Novaminsulfon (Dosages: 500mg, as needed)
  • Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.6 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234437
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Erythrocyte sedimentation rate (ESR) ... - C43.9

Donor:
Gender: Female Age: 48 Ethnic group: European/Caucasian
Diagnosed disease:
C43.9 - Malignant melanoma of skin, unspecified
Medication:
Novaminsulfon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
48 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
72 kg
Height:
159 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant melanoma of skin, unspecified [C43.9]
Medication:
  • Novaminsulfon (Dosages: 500mg, as needed)
  • Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.6 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234436
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - C50.9

Donor:
Gender: Female Age: 76 Ethnic group: European/Caucasian
Diagnosed disease:
C50.9 - Malignant neoplasm of breast, unspecified
Medication:
Aclasta
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
76 Years
Ethnic group:
European/Caucasian
BMI:
23 kg/m²
Weight:
67 kg
Height:
170 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of breast, unspecified [C50.9]
Medication:
  • Aclasta (Dosages: 5mg/6 months, active agent: zoledronic acid)
  • leflunomide (Dosages: 10mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.85 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 69.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241243
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - C50.9

Donor:
Gender: Female Age: 76 Ethnic group: European/Caucasian
Diagnosed disease:
C50.9 - Malignant neoplasm of breast, unspecified
Medication:
Aclasta
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
76 Years
Ethnic group:
European/Caucasian
BMI:
23 kg/m²
Weight:
67 kg
Height:
170 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of breast, unspecified [C50.9]
Medication:
  • Aclasta (Dosages: 5mg/6 months, active agent: zoledronic acid)
  • leflunomide (Dosages: 10mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.85 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 69.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241244
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Eryth... - C82.9

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
C82.9 - Follicular lymphoma, unspecified
Medication:
Metex
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
19 kg/m²
Weight:
58 kg
Height:
174 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Follicular lymphoma, unspecified [C82.9]
Medication:
  • Metex (Dosages: 15mg/week)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 11.10 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 21.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252424
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Capsule-reactive protein (CRP), Eryth... - C82.9

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
C82.9 - Follicular lymphoma, unspecified
Medication:
Metex
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
19 kg/m²
Weight:
58 kg
Height:
174 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Follicular lymphoma, unspecified [C82.9]
Medication:
  • Metex (Dosages: 15mg/week)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 11.10 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 21.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252425
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Capsule-reactive protein (CRP), Eryth... - C82.9

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
C82.9 - Follicular lymphoma, unspecified
Medication:
Metex
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
19 kg/m²
Weight:
58 kg
Height:
174 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Follicular lymphoma, unspecified [C82.9]
Medication:
  • Metex (Dosages: 15mg/week)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 11.10 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 21.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252423
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Capsule-reactive protein (CRP), Eryth... - D35.2

Donor:
Gender: Male Age: 62
Diagnosed disease:
D35.2 - Benign neoplasm of pituitary gland
Medication:
Enbrel
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF)
Donor:
Gender:
Male
Age:
62 Years
BMI:
27 kg/m²
Weight:
88 kg
Height:
182 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • DAS28-Score 2,02 (27.08.2018)
  • Swollen Joint Count (SJC) 0 (27.08.2018)
  • Tender Joint Count (TJC) 0 (27.08.2018)
  • Visual analogue scale (VAS) 30 mm (27.08.2018)
  • DAS28-Score 2,02 (27.08.2018)
  • Swollen Joint Count (SJC) 0 (27.08.2018)
  • Tender Joint Count (TJC) 0 (27.08.2018)
  • Visual analogue scale (VAS) 30 mm (27.08.2018)
  • DAS28-Score 2,02 (27.08.2018)
  • Swollen Joint Count (SJC) 0 (27.08.2018)
  • Tender Joint Count (TJC) 0 (27.08.2018)
  • Visual analogue scale (VAS) 30 mm (27.08.2018)
  • DAS28-Score 2,02 (27.08.2018)
  • Swollen Joint Count (SJC) 0 (27.08.2018)
  • Tender Joint Count (TJC) 0 (27.08.2018)
  • Visual analogue scale (VAS) 30 mm (27.08.2018)
Diseases:
  • Benign neoplasm of pituitary gland [D35.2]
Medication:
  • Enbrel (Dosages: 50mg/week, active agent: etanercept)
  • no other chronic medication
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual:
Quant: 1.11 mg/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 8.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF)
Qual:
Quant: 9.00 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH279112
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Bone alkaline phosphatase (BAP), Caps... - C81.1

Donor:
Gender: Female Age: 80
Diagnosed disease:
C81.1 - Nodular sclerosis (classical) Hodgkin lymphoma
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Proteinase 3 (PR3) Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Beta-CrossLaps (b-CTX) Bone alkaline phosphatase (BAP) Capsule-reactive protein (CRP) Complement C3 Complement C4 ...
Donor:
Gender:
Female
Age:
80 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Nodular sclerosis (classical) Hodgkin lymphoma [C81.1]
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: negative
Quant: 44.80 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Mutated citrullinated Vimentin (MCV)
Qual: negative
Quant: 5.80 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Myeloperoxidase (MPO)
Qual: negative
Quant: 1.70 U/mL
Source: this donation
< 5.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Proteinase 3 (PR3)
Qual: negative
Quant: 2.10 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: 1.00 RU/mL
Source: this donation
< 5.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Beta-CrossLaps (b-CTX)
Qual: negative
Quant: 0.154 ng/mL
Source: this donation
0.142 - 1.351 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Bone alkaline phosphatase (BAP)
Qual: positive
Quant: 43.70 µg/L
Source: this donation
5.50 - 27.10 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Capsule-reactive protein (CRP)
Qual: positive
Quant: 4.49 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.30 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.32 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Osteocalcin
Qual: negative
Quant: 12.20 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 32.50 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: < 1.00 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 11.10 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 6.70 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH286254
0.7 mL (€78.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Anti-cyclic citrullinated Peptide (CC... - D15.1

Donor:
Gender: Female Age: 48
Diagnosed disease:
D15.1 - Benign neoplasm of heart
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Hematokrit Rheumatoid Factor (RF)
Donor:
Gender:
Female
Age:
48 Years
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • in remission yes (2015-08)
  • in remission yes (2015-08)
  • in remission yes (2015-08)
  • in remission yes (2015-08)
  • in remission yes (2015-08)
Diseases:
  • Benign neoplasm of heart [D15.1]
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual:
Quant: 15 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Capsule-reactive protein (CRP)
Qual:
Quant: 4.9 mg/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 47 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hematokrit
Qual:
Quant: 0.43 %
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF)
Qual: negative
Quant: < 14.00 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH251813
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-cyclic citrullinated Peptide (CC... - D15.1

Donor:
Gender: Female Age: 48
Diagnosed disease:
D15.1 - Benign neoplasm of heart
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Hematokrit Rheumatoid Factor (RF)
Donor:
Gender:
Female
Age:
48 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • in remission yes (2015-08)
  • in remission yes (2015-08)
  • in remission yes (2015-08)
  • in remission yes (2015-08)
  • in remission yes (2015-08)
Diseases:
  • Benign neoplasm of heart [D15.1]
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual:
Quant: 15 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Capsule-reactive protein (CRP)
Qual:
Quant: 4.9 mg/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 47 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hematokrit
Qual:
Quant: 0.43 %
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF)
Qual: negative
Quant: < 14.00 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH251814
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Capsule-reactive protein (CRP) - C24.1

Donor:
Gender: Female Age: 48
Diagnosed disease:
C24.1 - Malignant neoplasm of ampulla of Vater
Parameter:
Capsule-reactive protein (CRP) Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
48 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • admission to the intensive care unit (ICU) yes (information given at the time donation)
  • specialty of the intensive care unit (ICU) general surgery (information given at the time donation)
  • admission to the intensive care unit (ICU) yes (information given at the time donation)
  • specialty of the intensive care unit (ICU) general surgery (information given at the time donation)
Diseases:
  • Malignant neoplasm of ampulla of Vater [C24.1]
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 86.40 mg/L
Source: this donation
< 5.00 mg/L
Method: Turbidimetry
System: cobas 6000 Roche
Procalcitonin (PCT)
Qual: negative
Quant: 0.10 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH281451
1.2 mL (€60.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C50.8

Donor:
Gender: Female Age: 55
Diagnosed disease:
C50.8 - Malignant neoplasm of overlapping lesion of breast
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
Gender:
Female
Age:
55 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of breast [C50.8]
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
< 10.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: Euroimmun Analyzer EUROIMMUN AG
Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Qual: negative
Quant: < 10.00  IU/mL
Source: this donation
< 10.00  IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH240780
0.9 mL (€22.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Thyroxine (FT4), Triiodothyronine (FT3) - C64

Donor:
Gender: Male Age: 40
Diagnosed disease:
C64
Parameter:
Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
40 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • kidney carcinoma [C64]
Parameter Result Ref. / Cut-Off Measuring Information
Thyroxine (FT4)
Qual:
Quant: 48.77 ng/L
Source: this donation
9,3 - 17,0 (adults) ng/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas 8000 Roche
Triiodothyronine (FT3)
Qual:
Quant: 12.03 pg/ml 
Source: this donation
2,00 - 4,40 (adults) pg/ml 
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas 8000 Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH281725
1.1 mL (€41.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C68.0

Donor:
Gender: Female Age: 87
Diagnosed disease:
C68.0 - Malignant neoplasm of urethra
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
Gender:
Female
Age:
87 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of urethra [C68.0]
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
< 10.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: Euroimmun Analyzer EUROIMMUN AG
Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 10.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH177392
1 mL (€50.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Thyroxine (FT4), Triiodothyronine (FT3) - C64

Donor:
Gender: Male Age: 40
Diagnosed disease:
C64
Parameter:
Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
40 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • kidney carcinoma [C64]
Parameter Result Ref. / Cut-Off Measuring Information
Thyroxine (FT4)
Qual:
Quant: 35.85 ng/L
Source: this donation
9,3 - 17,0 (adults) ng/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas 8000 Roche
Triiodothyronine (FT3)
Qual:
Quant: 9.45 pg/ml 
Source: this donation
2,00 - 4,40 (adults) pg/ml 
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas 8000 Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH281761
1.6 mL (€60.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human EDTA plasma - Neuron-specific enolase (NSE) - C80.9

Donor:
Gender: Male Age: 72
Diagnosed disease:
D35.0 - Benign neoplasm of adrenal gland
Parameter:
Neuron-specific enolase (NSE)
Donor:
Gender:
Male
Age:
72 Years
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm, primary site unspecified [C80.9]
  • Benign neoplasm of adrenal gland [D35.0]
Parameter Result Ref. / Cut-Off Measuring Information
Neuron-specific enolase (NSE)
Qual: positive
Quant: 28.90 µg/L
Source: this donation
< 15.00 µg/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH239680
1 mL (€75.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Cancer-Antigen 19-9 (CA 19-9) - C80.0

Donor:
Gender: Female Age: 68
Diagnosed disease:
C80.0 - Malignant neoplasm, primary site unknown, so stated
Parameter:
Cancer-Antigen 19-9 (CA 19-9)
Donor:
Gender:
Female
Age:
68 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm, primary site unknown, so stated [C80.0]
Parameter Result Ref. / Cut-Off Measuring Information
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 222.10 U/mL
Source: this donation
< 39 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH194699
0.4 mL (€65.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Alpha-1-Fetoprotein (AFP) - D35.2

Donor:
Gender: Male Age: 79
Diagnosed disease:
D35.2 - Benign neoplasm of pituitary gland
Parameter:
Alpha-1-Fetoprotein (AFP)
Donor:
Gender:
Male
Age:
79 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Benign neoplasm of pituitary gland [D35.2]
Parameter Result Ref. / Cut-Off Measuring Information
Alpha-1-Fetoprotein (AFP)
Qual: positive
Quant: 11.70 ng/mL
Source: this donation
< 10 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275681
0.4 mL (€65.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Cancer-Antigen 19-9 (CA 19-9) - D37.70

Donor:
Gender: Female Age: 85
Diagnosed disease:
D37.70
Parameter:
Cancer-Antigen 19-9 (CA 19-9)
Donor:
Gender:
Female
Age:
85 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • D37.70
Parameter Result Ref. / Cut-Off Measuring Information
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 84.00 U/mL
Source: this donation
< 39 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167100
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C44.6

Donor:
Gender: Male Age: 64
Diagnosed disease:
C44.6 - Malignant neoplasm of skin of upper limb, including shoulder
Parameter:
Protein S-100
Donor:
Gender:
Male
Age:
64 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of skin of upper limb, including shoulder [C44.6]
Parameter Result Ref. / Cut-Off Measuring Information
Protein S-100
Qual: negative
Quant: 0.03 µg/L
Source: this donation
< 0.11 µg/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH78657
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.8

Donor:
Gender: Male Age: 74
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
74 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 0.34 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167273
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - D48.0

Donor:
Gender: Male Age: 36
Diagnosed disease:
D48.0 - Neoplasm of uncertain or unknown behaviour of bone and articular cartilage
Parameter:
Alpha-1-Fetoprotein (AFP)
Donor:
Gender:
Male
Age:
36 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Neoplasm of uncertain or unknown behaviour of bone and articular cartilage [D48.0]
Parameter Result Ref. / Cut-Off Measuring Information
Alpha-1-Fetoprotein (AFP)
Qual: negative
Quant: 2.20 ng/mL
Source: this donation
< 10 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275564
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Lactate dehydrogenase (LDH) - C67.8

Donor:
Gender: Female Age: 53
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Lactate dehydrogenase (LDH)
Donor:
Gender:
Female
Age:
53 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Lactate dehydrogenase (LDH)
Qual: positive
Quant: 5.37 µmol/s/L
Source: this donation
< 4.16 µmol/s/L
Method: Photometry
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167207
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Prostate specific antigen (PSA), total - C67.8

Donor:
Gender: Male Age: 77
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
77 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: positive
Quant: 10.83 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275646
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C62.1

Donor:
Gender: Male Age: 16
Diagnosed disease:
C62.1 - Malignant neoplasm of descended testis
Parameter:
Alpha-1-Fetoprotein (AFP)
Donor:
Gender:
Male
Age:
16 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of descended testis [C62.1]
Parameter Result Ref. / Cut-Off Measuring Information
Alpha-1-Fetoprotein (AFP)
Qual: negative
Quant: 0.80 ng/mL
Source: this donation
< 10 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167364
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Cancer-Antigen 125 (CA 125) - C80.0

Donor:
Gender: Female Age: 68
Diagnosed disease:
C80.0 - Malignant neoplasm, primary site unknown, so stated
Parameter:
Cancer-Antigen 125 (CA 125)
Donor:
Gender:
Female
Age:
68 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm, primary site unknown, so stated [C80.0]
Parameter Result Ref. / Cut-Off Measuring Information
Cancer-Antigen 125 (CA 125)
Qual: positive
Quant: 121.70 U/mL
Source: this donation
< 35 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH194708
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Cancer-Antigen 125 (CA 125) - C80.0

Donor:
Gender: Female Age: 68
Diagnosed disease:
C80.0 - Malignant neoplasm, primary site unknown, so stated
Parameter:
Cancer-Antigen 125 (CA 125)
Donor:
Gender:
Female
Age:
68 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm, primary site unknown, so stated [C80.0]
Parameter Result Ref. / Cut-Off Measuring Information
Cancer-Antigen 125 (CA 125)
Qual: positive
Quant: 43.60 U/mL
Source: this donation
< 35 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH194710
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)
  • <
  • 1
  • ...
  • ...
  • ...
  • ...